FIGURE 2.

Multivariable-adjusted association of change in body weight with probability of developing sarcopenia during follow-up among patients without sarcopenia at baseline (A); developing myosteatosis at follow-up among patients without myosteatosis at baseline (B); resolution of sarcopenia at follow-up among patients with sarcopenia at baseline (C); and resolution of myosteatosis at follow-up among patients with myosteatosis at baseline (D), among men (navy blue) and women (magenta). Weight-stable men (n = 548) were less likely to develop incident sarcopenia (5.4% compared with 15.4%; P = 0.003) and myosteatosis (9.3% compared with 20.8%; P = 0.001) than were weight-stable women (n = 478). Weight-stable men (n = 548) were more likely to experience resolution of prevalent sarcopenia (34.6% compared with 11.7%; P < 0.001) but not resolution of prevalent myosteatosis (17.7% compared with 15.7%; P = 0.72) than were weight-stable women (n = 478). Solid lines represent point estimates and shaded areas represent the corresponding 95% CIs estimated from a multivariable-adjusted logistic regression model.